Inclusive Innovation in Emerging Markets: A Biosimilars Technology Dynamics Case

With developed markets approaching saturation, multinational corporations are directing their attention and resources towards emerging market economies (EMEs). Traditionally, multinational companies (MNCs) target the top of the economic pyramid, represented by the wealthy elite. However, there is a visible trend in MNCs exploring the potential...